Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now

2 days ago 3

Maham Fatima

Sun, May 17, 2026 astatine 11:49 PM CDT 2 min read

Invivyd Inc. (NASDAQ:IVVD) is 1 of the best NASDAQ stocks nether $5 to bargain close now. On May 14, Invivyd reported net for Q1 2026, highlighted by $13.7 cardinal successful PEMGARDA nett merchandise revenue, which marks a 22% maturation compared to Q1 2025. The institution ended the 4th with $184.2 cardinal successful currency and currency equivalents, supplemented by ~$20 cardinal successful gross proceeds from an April at-the-market offering. R&D expenses roseate to $30.7 million, and selling, general, & administrative expenses accrued to $25.1 million, resulting successful a nett nonaccomplishment of $41.4 cardinal for the quarter.

The summation successful operating expenses was chiefly driven by the ongoing DECLARATION Phase 3 objective proceedings for VYD2311, an investigational COVID-19 monoclonal antibody candidate. Initial afloat enrollment for the proceedings was achieved successful March, and a consequent illustration size re-estimation successful April added ~500 subjects, shifting the anticipation of top-line information to Q3. Based connected an advertisement hoc information review, the trial’s Independent Data Monitoring Committee recommended reducing post-dose monitoring from 2 hours to 30 minutes, eliminated definite follow-up visits, and updated eligibility to see large and breastfeeding women.

10 Best NASDAQ Stocks Under $5 to Buy Right Now

In laboratory assessments, some PEMGARDA and VYD2311 showed continued successful vitro neutralizing enactment against the SARS-CoV-2 BA.3.2.2 (“Cicada”) variant. Looking forward, Invivyd Inc. (NASDAQ:IVVD) is preparing for the LIBERTY Phase 3 proceedings comparing VYD2311 to mRNA vaccines, a Phase 2 proceedings for Long COVID and vaccine injury, and pediatric evaluations via the DRUMMER trial. Beyond COVID-19, the institution is advancing its pipeline with improvement plans for VMS063 for measles and VBY329 for pediatric respiratory syncytial virus/RSV prophylaxis, targeting investigational caller cause readiness for some candidates successful precocious 2026.

Invivyd Inc. (NASDAQ:IVVD) develops next‑generation antibody drugs aimed astatine long‑lasting effectiveness against evolving viruses, utilizing a proprietary level to present durable therapies.

While we admit the imaginable of IVVD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article